ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ASXC Asensus Surgical Inc

0.2452
-0.0014 (-0.57%)
Last Updated: 18:28:35
Delayed by 15 minutes
Share Name Share Symbol Market Type
Asensus Surgical Inc AMEX:ASXC AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0014 -0.57% 0.2452 0.2538 0.24 0.2433 349,192 18:28:35

Asensus Surgical to Participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference

28/11/2022 11:55am

GlobeNewswire Inc.


Asensus Surgical (AMEX:ASXC)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Asensus Surgical Charts.

Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference in Miami, Florida. The Company’s panel presentation, Launching on Society: Early Commercial MedTech Names with New Technologies in Large Patient Populations, will take place on Thursday, December 8, 2022 at 11:00 AM Eastern Time. A Key Opinion Leader Luncheon presentation, A Discussion on Robotic Devices in Surgery, will also be held on Thursday, December 8, 2022 at 12:15 PM Eastern Time, featuring Dr. Steven McCarus,Chief of Gynecology Surgery at AdventHealth Winter Park, Florida.

About Asensus Surgical, Inc.

Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.

Follow Asensus

  • Email Alerts: https://ir.asensus.com/email-alerts
  • LinkedIn: https://www.linkedin.com/company/asensus-surgical-inc
  • Twitter: https://twitter.com/AsensusSurgical
  • YouTube: https://www.youtube.com/c/transenterix
  • Vimeo: https://vimeo.com/asxc
  • TikTok: https://www.tiktok.com/@asensus_surgical

INVESTOR CONTACT:Mark Klausner or Mike Vallie, 443-213-0499invest@asensus.comorMEDIA CONTACT:Isabella Rodriguez, 708-833-1572CG Lifeirodriguez@cglife.com

1 Year Asensus Surgical Chart

1 Year Asensus Surgical Chart

1 Month Asensus Surgical Chart

1 Month Asensus Surgical Chart

Your Recent History

Delayed Upgrade Clock